Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura
Abstract
To compare the prevalence of Helicobacter pylori (H pylori) infection in autoimmune thrombocytopenic purpura (AITP) patients with that of nonthrombocytopenic controls, and to evaluate the efficacy of the treatment in H pylori(+) and H pylori(-) AITP patients. The prevalence of gastric H pylori infection in 38 adult AITP patients (29 female and 9 male; median age 27 years; range 18-39 years) who consecutively admitted to our clinic was investigated. H pylori infection was found in 26 of 38 AITP patients (68.5%). H pylori infection was found in 15 of 23 control subjects (65.2%). The difference in H pylori infection between the 2 groups was not significant. Thrombocyte count of H pylori-positive AITP patients was significantly lower than that of H pylori-negative AITP patients (P<0.05). Thrombocyte recovery of H pylori-positive group was less than that of H pylori-negative group (P<0.05). H pylori infection should be considered in the treatment of AITP patients with H pylori infection.
References
Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis
Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura.
Citations
Related Concepts
Related Feeds
Autoimmune Diseases
Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.